scispace - formally typeset
F

Frank Baas

Researcher at Leiden University Medical Center

Publications -  446
Citations -  33815

Frank Baas is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Gene & Complement system. The author has an hindex of 93, co-authored 434 publications receiving 31187 citations. Previous affiliations of Frank Baas include Flanders Institute for Biotechnology & Academic Medical Center.

Papers
More filters
Journal ArticleDOI

Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas

TL;DR: A four-hit mechanism of tumour suppressor gene inactivation, involving SMARCB1 and NF2, might be operative in familial multiple meningiomas associated mening iomas.
Journal ArticleDOI

Statistical evaluation of SAGE libraries: consequences for experimental design

TL;DR: A comparison showed that, for SAGE libraries of equal as well as different size, SAGE300, Fisher's Exact test, Z test, and the Audic and Claverie test have critical values within 1.5% of each other, which indicates that these four tests will give essentially the same results when applied to Sage libraries.
Journal ArticleDOI

Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo

TL;DR: The destabilizing properties of UNA are well suited to enhance the potency of siRNAs which are heavily modified by other chemical modifications such as locked nucleic acid (LNA), C4'hydroxymethyl-DNA (HM), 2'-O-methyl-RNA (OMe), DNA and 2'-Flouro-DNA
Journal ArticleDOI

Allelotype of pediatric rhabdomyosarcoma

TL;DR: The data suggest that genes involved in the development of RMS and WT may not only be similar for chromosome 11 but also for chromosome 16, and that LOH of chromosome 16 is also found in other tumors, including WT.
Journal ArticleDOI

Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.

TL;DR: It is concluded that the SMARCB1 exon 2 missense mutation in this family predisposes to the development of meningiomas as well as schwannomas, occurring via the same genetic pathways, and that this mutation preferentially induces cranial meningIomas located at the falx cerebri.